- Sitagliptin +12008 | Second Faculty of Medicine
- Sitagliptin (Januvia)2007 | Second Faculty of Medicine
- Sitagliptin in 2012 - the current knowledge about the first DPP-4 inhibitor2012 | Second Faculty of Medicine
- Sitagliptin is safe alternative in the treatment of the light renal insuficiency2008 | Second Faculty of Medicine
- Sitagliptin is effective in combination with metformin and gliclazide2009 | Second Faculty of Medicine
- Heart failure and sitagliptin - Commentary2016 | Second Faculty of Medicine
- Sitagliptin for 2013 year2013 | Second Faculty of Medicine
- Fixed combination of sitagliptin and metformin2009 | Second Faculty of Medicine
- Clinical efficacy of sitagliptin and vildagliptin2009 | Second Faculty of Medicine
- Comparison of clinical efficacy of DPP-4 inhibitors sitagliptin and vildagliptin2009 | Second Faculty of Medicine
- Importance of sitagliptin for modern treatment of type 2 diabetes mellitus2009 | Second Faculty of Medicine
- Type 2 diabetic patient treated with sitagliptin2008 | Second Faculty of Medicine
- Sitagliptin may reduce mortality in type 2 diabetics hospitalized for COVID-192021 | Second Faculty of Medicine
- Annual monitoring of side effects of administering sitagliptin in patients with type 2 diabetes mellitus2016 | First Faculty of Medicine, Third Faculty of Medicine
- Sitagliptin monotherapy in type II. diabetic patients2010 | Faculty of Medicine in Pilsen
- A simple change in therapy can make the patient happy - the benefits of a change from glimepiride to sitagliptin2020 | Publication without faculty affiliation
- The achievement of a long lasting stable compensation of the type 2 diabetes mellitus during the combined treatment with sitagliptin and metformin2016 | Faculty of Medicine in Pilsen
- Sitagliptin and metformin as an ideal combination for the treatment of type 2 diabetes2009 | Second Faculty of Medicine
- Case 3: The combination of metformin with sitagliptin improves DM compensation2009 | Second Faculty of Medicine
- Role of sitagliptin in the treatment of type 2 diabetes based on the results of the TECOS study2016 | Second Faculty of Medicine
- Incretin strategy in the treatment of type 2 diabetes mellitus - the DPP-IV inhibitor sitagliptin2007 | Second Faculty of Medicine
- Sitagliptin pro rok 20162016 | Second Faculty of Medicine
- Sitagliptin in 20122012 | Second Faculty of Medicine
- Sitagliptin - first inhibitor of DPP-42011 | Second Faculty of Medicine
- A comparison between sitagliptin or glibenclamide in addition to metformin + piglitazone on glycaemic control and b-cell function: the triple oral therapy2013 | Second Faculty of Medicine
- Sitagliptin prokázal lepší glykemickou kompenzaci než dapagliflozin u nekompenzovaných diabetiků 2. typu s mírnou renální insuficiencí2018 | Second Faculty of Medicine
- Sitagliptin versus semaglutide in type 2 diabetes mellitus2020 | Second Faculty of Medicine
- Dynamic Change of Focal Fatty Sparing in Non-Alcoholic Fatty Liver Disease after Treatment with Sitagliptin2016 | Third Faculty of Medicine
- Sitagliptin rok po studii TECOS: lék první volby s metforminem?2016 | Second Faculty of Medicine